Blockade of latent inhibition following pharmacological increase or decrease of GABA(A) transmission. (Q52165516)

26 April 2018

title

Blockade of latent inhibition following pharmacological increase or decrease of GABA(A) transmission. (English)

1 reference

26 April 2018

author

Laurent P Lacroix

1

1 reference

26 April 2018

author name string

Spinelli S

2

1 reference

26 April 2018

Broersen LM

3

1 reference

26 April 2018

Feldon J

4

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

66

1 reference

26 April 2018

issue

4

1 reference

26 April 2018

page(s)

893-901

1 reference

26 April 2018

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Vigabatrin and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Effects of desipramine and alprazolam in the forced swim test in rats after long-lasting termination of chronic exposure to picrotoxin and pentylenetetrazol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

A behavioural and pharmacological evaluation of the discriminative stimulus induced by pentylenetetrazole in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Combined effects of chlordiazepoxide treatment and food deprivation on concurrent measures of feeding and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Gaba and endorphln mechanisms in relation to the effects of benzodiazepines on feeding and drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Decrease in the Function of the ?-Aminobutyric Acid-Coupled Chloride Channel Produced by the Repeated Administration of Pentylenetetrazol to Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Behavioral effects of benzodiazepines: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Benzodiazepines and GABA hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Chronic infusions of GABA into the medial frontal cortex of the rat induce a reversible delayed spatial alternation deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Differential effects of benzodiazepine receptor ligands on isotonic saline and water consumption in water-deprived rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Integrating schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Benzodiazepine interactions with GABA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Novel anxiolytics that act as partial agonists at benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Selective antagonists of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Ethanol self-administration in freely feeding and drinking rats: effects of Ro15-4513 alone, and in combination with Ro15-1788 (flumazenil).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Interactions of Ro15-4513, Ro15-1788 (flumazenil) and ethanol on measures of exploration and locomotion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

WAY100635 and latent inhibition in the rat: selective effects at preexposure

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

From binding studies to the molecular biology of GABA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Extinction of fear II: Effects of chlordiazepoxide and chlorpromazine on fear and exploratory behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Diazepam and decision making in the rat: negative evidence for reduced tolerance to reward delay.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Impairment of decision making in rats by diazepam: implications for the "anticonflict" effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Effects of various depressant drugs on deprivation-induced water consumption.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

GABA and acute psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

1 reference

7 January 2021

Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-gaba receptor-ionophore complex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Vigabatrin and behaviour disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The case of frontostriatal dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Latent inhibition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Muscimol: GABA agonist therapy in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Effects of nicotine and amphetamine on latent inhibition in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Latent inhibition and autonomic responses: a psychophysiological approach

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Neural substrates of latent inhibition: the switching model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The switching model of latent inhibition: an update of neural substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The abolition of the partial reinforcement extinction effect (PREE) by amphetamine: disruption of control by nonreinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

Nucleus basalis magnocellularis and attention: effects of muscimol infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900269-0

7 January 2021

10.1016/S0091-3057(00)00269-0

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018